NCT05896371: A Phase 1/2 Study of Personalized PSMA Radiopharmaceutical Therapy
- State
- Not started
- Phase
- Phase 1 and Phase 2
- People
- 500 planned
- Started
- Mar 2028
- Primary completion
- Mar 2033
- Arms
- Cohort A, Cohort B, Cohort C, Cohort D, Cohort E
- Results
- None posted
- 9 Jun 2023: Trial registered